Jan Haudemann-Andersen, member of the Vaccibody AS board, owns 100% of the shares in Datum Opportunity AS and Datum AS.

Datum AS has today bought 25,000,000 shares in Vaccibody AS from Datum Opportunity AS at NOK 73.50 per share.
After the above transactions Datum AS holds 32,505,000 and Datum Opportunity AS holds no Shares in Vaccibody AS.

The Datum Group holds an unchanged number of 40,133,800 shares in Vaccibody AS after the above transactions.